LENZ Therapeutics (LENZ) Inventory (2020 - 2026)

LENZ Therapeutics (LENZ) has 6 years of Inventory data on file, last reported at $3.5 million in Q1 2026.

• Quarterly Inventory changed N/A year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (changed N/A YoY) and the FY2025 annual result came in at $2.9 million, changed N/A from the prior year.
• Inventory improved to $3.5 million in Q1 2026 per LENZ's latest filing, from $2.9 million in the prior quarter.
• Across five years, Inventory topped out at $3.5 million in Q1 2026 and bottomed at $39000.0 in Q2 2023.
• The 4-year median for Inventory is $2.1 million (2023), against an average of $2.0 million.
• The widest annual swing landed in 2022, when Inventory surged 35.55%; it then sank 97.68% in 2023.
• Tracing LENZ's Inventory over 4 years: stood at $2.5 million in 2022, then slumped by 98.43% to $39000.0 in 2023, then jumped by 7428.21% to $2.9 million in 2025, then grew by 19.14% to $3.5 million in 2026.
• Per Business Quant, the three latest LENZ Inventory figures stand at $3.5 million (Q1 2026), $2.9 million (Q4 2025), and $949000.0 (Q3 2025).

Peer Comparison